HDAC2 and Cerebral ischemia: For example, according to the findings presented by Jia T et al. [205], activation of miR-489-3p expression in in vivo and in vitro models reduces the pathological consequences of cerebral ischemia–reperfusion by inhibiting histone deacetylase 2 (HDAC2), thereby reducing apoptosis intensity and enhancing cell viability.